Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis

Marshall, Richard H., Eissa, Marna, Bluth, Edward I., Gulotta, Paul M. and Davis, Nancy K. (2012) Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. American Journal of Roentgenology, 199 5: 997-1002. doi:10.2214/AJR.11.6677

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Marshall, Richard H.
Eissa, Marna
Bluth, Edward I.
Gulotta, Paul M.
Davis, Nancy K.
Title Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis
Journal name American Journal of Roentgenology   Check publisher's open access policy
ISSN 0361-803X
Publication date 2012-11
Sub-type Article (original research)
DOI 10.2214/AJR.11.6677
Open Access Status
Volume 199
Issue 5
Start page 997
End page 1002
Total pages 6
Place of publication Leesburg, VA, United States
Publisher American Roentgen Ray Society
Collection year 2013
Language eng
Formatted abstract
OBJECTIVE. The hepatorenal index has been reported to be a sensitive and noninvasive test to quantify steatosis, but it is cumbersome and time-consuming and requires specialized software. The aim of this study was to improve and simplify the hepatorenal index calculation and determine whether it is an effective tool for differentiating patients with steatosis from those without steatosis, thereby eliminating the need for biopsy in a large number of patients.

MATERIALS AND METHODS. One hundred one patients who had undergone ultrasound-guided percutaneous liver biopsy at our institution were selected from a patient database. Patients with renal disease, patients with liver masses, and patients whose liver and right kidney were not included on the same image were excluded. Images were acquired with high-resolution ultrasound, and the hepatorenal index was calculated using freeware based on comparison of hepatic and renal brightness.

. Of the 101 patients, 63 had 5% or less steatosis and 38 had more than 5% steatosis. Using freeware available online from the National Institutes of Health, we calculated hepatorenal index values for all patients. Our data showed a strong correlation between the hepatorenal index and percentage of fat (r = 0.71, p < 0.0001). A hepatorenal index of 1.28 or greater had a 100% sensitivity for identifying more than 5% fat, 54% specificity, 0.57 positive predictive value, and 1.0 negative predictive value. If this method had been used prospectively to select patients for biopsy in our sample, 34% of biopsies could have been avoided.

CONCLUSION. The hepatorenal index is a simple, reliable, and cost-effective screening tool for identifying patients who should not undergo liver biopsy for evaluation of steatosis.
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2013 Collection
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 10 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 12 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 28 Nov 2012, 12:37:52 EST by Matthew Lamb on behalf of School of Medicine